Загрузка...
Open-label add-on treatment trial of minocycline in fragile X syndrome
BACKGROUND: Fragile X syndrome (FXS) is a disorder characterized by a variety of disabilities, including cognitive deficits, attention-deficit/hyperactivity disorder, autism, and other socio-emotional problems. It is hypothesized that the absence of the fragile X mental retardation protein (FMRP) le...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2958860/ https://ncbi.nlm.nih.gov/pubmed/20937127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-10-91 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|